Castle Biosciences, Inc. (NASDAQ: CSTL)
$26.8000
+0.3000 ( +1.17% ) 96.6K
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Market Data
Open
$26.8000
Previous close
$26.5000
Volume
96.6K
Market cap
$742.19M
Day range
$25.7420 - $27.0440
52 week range
$16.9650 - $35.8400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Aug 27, 2024 |
| 4 | Insider transactions | 1 | Aug 14, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Aug 05, 2024 |
| 10-q | Quarterly Reports | 75 | Aug 05, 2024 |
| 8-k | 8K-related | 67 | Aug 05, 2024 |